RT Journal Article
T1 Synthetic biology approaches to actinomycete strain improvement.
A1 Breitling, Rainer
A1 Avbelj, Martina
A1 Bilyk, Oksana
A1 Carratore, Francesco Del
A1 Filisetti, Alessandro
A1 Hanko, Erik K R
A1 Iorio, Marianna
A1 Redondo, Rosario Pérez
A1 Reyes, Fernando
A1 Rudden, Michelle
A1 Severi, Emmanuele
A1 Slemc, Lucija
A1 Schmidt, Kamila
A1 Whittall, Dominic R
A1 Donadio, Stefano
A1 García, Antonio Rodríguez
A1 Genilloud, Olga
A1 Kosec, Gregor
A1 De Lucrezia, Davide
A1 Petković, Hrvoje
A1 Thomas, Gavin
A1 Takano, Eriko
K1 actinobacteria
K1 actinomycete
K1 biosynthesis
K1 biotechnology
K1 synthetic biology
AB Their biochemical versatility and biotechnological importance make actinomycete bacteria attractive targets for ambitious genetic engineering using the toolkit of synthetic biology. But their complex biology also poses unique challenges. This mini review discusses some of the recent advances in synthetic biology approaches from an actinomycete perspective and presents examples of their application to the rational improvement of industrially relevant strains.
YR 2021
FD 2021
LK http://hdl.handle.net/10668/17855
UL http://hdl.handle.net/10668/17855
LA en
DS RISalud
RD Apr 8, 2025